How diabetes treatment affects microRNAs in the body
The Impact of Interventions to Treat Incident Diabetes on Circulating microRNAs in the Diabetes Prevention Program
This study is looking at tiny molecules in your blood that might help predict if you'll develop type 2 diabetes and how they change with lifestyle changes or medications like metformin, so we can find better ways to prevent and manage diabetes for people at risk.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10545053 on NIH RePORTER |
What this research studies
This research investigates the role of circulating microRNAs in predicting the onset of type 2 diabetes and how they respond to lifestyle changes and medications like metformin. By analyzing blood samples from participants in the Diabetes Prevention Program, the study aims to understand the interactions between genetic predisposition and lifestyle factors in diabetes risk. The research focuses on identifying specific microRNAs that may serve as biomarkers for diabetes and evaluating their changes in response to various interventions. This approach could lead to more personalized strategies for diabetes prevention and management.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults at risk for type 2 diabetes, particularly those who are overweight or have a family history of the disease.
Not a fit: Patients who are already diagnosed with type 2 diabetes or those who do not have risk factors for the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide new biomarkers for early detection of type 2 diabetes and improve prevention strategies.
How similar studies have performed: Previous studies have shown promise in using microRNAs as predictive biomarkers for diabetes, indicating that this approach has potential based on earlier findings.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Flowers, Elena — University of California, San Francisco
- Study coordinator: Flowers, Elena
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.